Canopy Growth Corporation (CGC)
Canopy Growth Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Smiths Falls, ON, CA. The stock last traded at $0.94, up 1.35% on the session, giving a market capitalisation of $397.5M. On trailing twelve-month figures it carries a trailing P/E of -2.00, a net margin of -73.9%. Its beta of 2.41 implies it has historically moved more than the broad market.
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Canopy Growth Corporation is most often compared with the following Healthcare names: